Hypermethylation and recruitment of dysregulated methyltransferases were hypothesized as mechanisms for defective CIITA and HLA-II expression in metastatic breast cancer [65], [66], but these studies were based on a presumed breast cancer cell line MDA-MB-435. The gene discussed is CIITA; the disease is breast cancer.